Leukemia Clinical Trials in Boston

Showing 1441-1445 of 1,445 trials

Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer

NCT00074867

The purpose of this study is to determine whether CP-547,632, an oral VEGFR-2 tyrosine kinase inhibitor is effective in the treatment of epithelial ovarian cancer, primary peritoneal serous cancer, or fallopian tube cancer for patients who have failed first line platinum-based therapy and have a persistent rising CA-125.

Ovarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms

Pfizer29 participantsStarted Oct 2003

Los Angeles, California, United States • Santa Monica, California, United States • Baltimore, Maryland, United States +6 more locations

TERMINATEDPhase 2< 1 mile

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT00129948

This is a phase 2, single-arm, open-label, multi-center study to establish the safety and efficacy of Troxatyl™ (troxacitabine) administered as a continuous infusion for 5 days to subjects with AML.

Leukemia, Myeloid, Acute

SGX Pharmaceuticals, Inc.211 participantsStarted Jul 2005

La Jolla, California, United States • Los Angeles, California, United States • San Diego, California, United States +17 more locations

Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Leukemia Trials in Other Cities

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

CP-481,715 Nickel Allergy Study.

Other Conditions in Boston